LATAM Bif Registry
Latin American Registry of Percutaneous Interventions in Coronary Bifurcations
1 other identifier
observational
5,000
0 countries
N/A
Brief Summary
The LATAM Bif Registy is an international and prospective registry of percutaneous coronary interventions (PCI) in coronary bifurcation lesions. The main goal of the study is to investigate the current state and long-term outcomes of PCI in this complex subset of coronary lesions in Latin America.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2020
CompletedFirst Posted
Study publicly available on registry
July 15, 2020
CompletedStudy Start
First participant enrolled
August 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2030
ExpectedJuly 15, 2020
July 1, 2020
5 years
July 10, 2020
July 10, 2020
Conditions
Outcome Measures
Primary Outcomes (5)
Cardiac Death
5 years
Myocardial Infarction
5 years
Target Lesion Revascularization
5 years
Stent thrombosis
5 years
Major bleeding
5 years
Interventions
Percutaneous coronary interventions in coronary bifurcation lesions
Eligibility Criteria
All patients ≥18 years of age, who have at least one significant lesion in a coronary bifurcation on diagnostic cinecoronary angiography and who are candidates to treatment with PCI, regardless of the dedicated-technique used. Those patients who present lesions involving vessels \<2 mm by visual estimation and those who refuse to be included in the registry will be excluded.
You may qualify if:
- Age \>= 18 years
- Any type of bifurcation lesion
- Side-branch reference diameter \>= 2 mm
You may not qualify if:
- Protected left main disease in patients with previous CABG
- Patients who refuse to be included in the registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2020
First Posted
July 15, 2020
Study Start
August 15, 2020
Primary Completion
August 15, 2025
Study Completion (Estimated)
August 15, 2030
Last Updated
July 15, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share
No IPD planned